重组人NKp30/NCR3/CD337(hFc标签)|Recombinant Human NKp30/NCR3/CD337(94131ES)
产品应用
NKp30 is a type I transmembrane protein having a single extracellular V-like immunoglobulin domain. NKp30 is expressed on both resting and activated NK cells of the CD56dim, CD16+ subset that account for more that 85% of NK cells found in peripheral blood and spleen. NKp30 is absent from the CD56bright, CD16- subset that constitutes the majority of NK cells in lymph node and tonsil, however, its expression is up-regulated in these cells upon IL-2 activation. Studies with neutralizing antibodies reveal that NKp30 is partially responsible for triggering lytic activity against several tumor cell types and that it is the main receptor responsible for NK-mediated lysis of immature dendritic cells.
高纯度、高活性、低内毒素、高批间一致性
产品数据


-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
299
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
306
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
385
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
287
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
2308
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
2172
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1324
2026-04-22
【应用方向】TNFR蛋白家族概述
1304
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1501
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
1087
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
1123
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1242
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
994
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14832
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11428
2026-09-21





